Polymotion® Hip Resurfacing IDE Study Hits Full Enrolment Milestone
A defining achievement has been reached in the evolution of hip preservation technology, the Polymotion® Hip Resurfacing (PHR®) IDE study has officially achieved full enrolment. On Friday, April 3rd, Dr. William Macaulay at NYU Langone performed the final procedure, bringing recruitment to a close and highlighting the growing interest in bone-conserving treatment options for young, active patients.
JointMedica Announces Launch of IDE Study for Polymotion® Hip Resurfacing System
JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device. The IDE study aims to evaluate the safety and clinical effectiveness of the Polymotion® Hip Resurfacing System to address the challenges faced by younger, more active patients.
